Literature DB >> 17605300

Widespread, exceptionally high levels of histone H3 lysine 4 trimethylation largely mediate "privileged" gene expression.

Li Chen1, Pervez Firozi, Michelle Barton, Nancy Smyth Templeton.   

Abstract

We examined the molecular determinants for sustained high-level expression of "privileged" genes, defined as the 0.03% most highly expressed genes within any specific cell. We identified histone modifications by chromatin immunoprecipitation analyses on Keratin 8, the most highly expressed gene in the human breast cancer cell line, MCF-7, based on serial analysis of gene expression. Quantitative comparisons to the "normal" counterpart cell line, MCF-10A, expressing 350-fold lower levels of Keratin 8 and other breast cancer cell lines expressing higher levels were performed using real-time PCR. Extraordinarily high levels of trimethyl histone H3 lysine 4 (H3K4) were found primarily in the first intron of the Keratin 8 gene stretching from 400 to 2000 bp downstream from the promoter in all breast cancer cells lines but not in MCF-10A cells. The highest levels of histone H3K4 trimethylation in MCF-7 cells ranged from 70% to 80% over input within 1200 bp of this region. Knockdown of mixed-lineage leukemia (MLL), the specific methyltransferase for histone H3K4, with MLL-specific siRNA decreased histone H3K4 trimethylation on the Keratin 8 gene and decreased Keratin 8 mRNA levels. Histone H3K4 trimethylation mediates approximately 86% of the elevated, sustained expression of the Keratin 8 gene in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17605300      PMCID: PMC6032458          DOI: 10.3727/000000006780666966

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  26 in total

1.  ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.

Authors:  Tatsuya Nakamura; Toshiki Mori; Shinichiro Tada; Wladyslaw Krajewski; Tanya Rozovskaia; Richard Wassell; Garrett Dubois; Alexander Mazo; Carlo M Croce; Eli Canaani
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

2.  Genome-wide map of nucleosome acetylation and methylation in yeast.

Authors:  Dmitry K Pokholok; Christopher T Harbison; Stuart Levine; Megan Cole; Nancy M Hannett; Tong Ihn Lee; George W Bell; Kimberly Walker; P Alex Rolfe; Elizabeth Herbolsheimer; Julia Zeitlinger; Fran Lewitter; David K Gifford; Richard A Young
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

Review 3.  Heterochromatin protein 1: don't judge the book by its cover!

Authors:  Florence Hediger; Susan M Gasser
Journal:  Curr Opin Genet Dev       Date:  2006-02-28       Impact factor: 5.578

4.  Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment.

Authors:  M David Stewart; Jiwen Li; Jiemin Wong
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation.

Authors:  T A Hembrough; K R Kralovich; L Li; S L Gonias
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

6.  Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries.

Authors:  C D Allis; S I Grewal
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

7.  MLL targets SET domain methyltransferase activity to Hox gene promoters.

Authors:  Thomas A Milne; Scott D Briggs; Hugh W Brock; Mary Ellen Martin; Denise Gibbs; C David Allis; Jay L Hess
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

8.  Immunohistochemical analysis of cytokeratin #8 as a prognostic factor in invasive breast carcinoma.

Authors:  H Takei; Y Iino; J Horiguchi; T Kanoh; Y Takao; T Oyama; Y Morishita
Journal:  Anticancer Res       Date:  1995 May-Jun       Impact factor: 2.480

9.  Cytokeratin expression in breast cancer: phenotypic changes associated with disease progression.

Authors:  I Brotherick; C N Robson; D A Browell; J Shenfine; M D White; W J Cunliffe; B K Shenton; M Egan; L A Webb; L G Lunt; J R Young; M J Higgs
Journal:  Cytometry       Date:  1998-08-01

10.  Cytokeratins are exposed on the outer surface of established human mammary carcinoma cells.

Authors:  E Godfroid; M Geuskens; T Dupressoir; I Parent; C Szpirer
Journal:  J Cell Sci       Date:  1991-07       Impact factor: 5.285

View more
  4 in total

Review 1.  Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer.

Authors:  Moonmoon Deb; Swayamsiddha Kar; Dipta Sengupta; Arunima Shilpi; Sabnam Parbin; Sandip K Rath; Vedang A Londhe; Samir Kumar Patra
Journal:  Cell Mol Life Sci       Date:  2014-03-28       Impact factor: 9.261

2.  Renal ischemia-induced cholesterol loading: transcription factor recruitment and chromatin remodeling along the HMG CoA reductase gene.

Authors:  Masayo Naito; Karol Bomsztyk; Richard A Zager
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

3.  Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure.

Authors:  Masayo Naito; Karol Bomsztyk; Richard A Zager
Journal:  J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 10.121

4.  Optimization of Non-Viral Gene Therapeutics Using Bilamellar Invaginated Vesicles.

Authors:  Nancy Smyth Templeton; Neil Senzer
Journal:  J Genet Syndr Gene Ther       Date:  2011-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.